Duvelisib (R enantiomer)

CAS No. 1261590-48-0

Duvelisib (R enantiomer)( IPI-145 R enantiomer | INK1197 R enantiomer | Duvelisib R enantiomer )

Catalog No. M26184 CAS No. 1261590-48-0

Duvelisib R enantiomer is an enantiomer of Duvelisib with lower activity. Duvelisib is a PI3K inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 104 Get Quote
50MG 325 Get Quote
100MG 554 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Duvelisib (R enantiomer)
  • Note
    Research use only, not for human use.
  • Brief Description
    Duvelisib R enantiomer is an enantiomer of Duvelisib with lower activity. Duvelisib is a PI3K inhibitor.
  • Description
    Duvelisib R enantiomer is an enantiomer of Duvelisib with lower activity. Duvelisib is a PI3K inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IPI-145 R enantiomer | INK1197 R enantiomer | Duvelisib R enantiomer
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1261590-48-0
  • Formula Weight
    416.87
  • Molecular Formula
    C22H17ClN6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (239.89 mM)
  • SMILES
    C[C@@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang G, Becker E, Mesa C. Optimization of 6-carboxy-X-rhodamine concentration for real-time polymerase chain reaction using molecular beacon chemistry. Can J Microbiol. 2007 Mar;53(3):391-7.
molnova catalog
related products
  • BAY 1082439

    BAY 1082439 is a potent, highly selective, orally available PI3Kα/β inhibitor, selectively inhibits both PI3Kα.

  • NSC5844

    NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.

  • PI3Kα-IN-4h

    PI3Kα-IN-1 is a potent, selective, ATP-competitive dual PI3Kα/mTOR inhibitor with IC50 of 0.5/104 nM respectively.